comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists in Diseases: Mechanisms, Clinical Evidence, Emerging Therapies SGLT2 Inhibitors and GLP-1 Receptor
Description
This suggests that metformin-induced glucose reduction is dependent on SGLT1 expression (Zubiaga et al., 2023)
Personalized Plans: One-size-fits-all diets rarely work
Sobos approach to peptide therapy focuses on medical evaluation, personalization, dosing clarity, monitoring, and patient education
Rybelsus is FDA-approved specifically for type 2 diabetes treatment
Malaty HM, Kim JG, Kim SD, Graham DY
To manage cholesterol changes while also losing weight, check out this cholesterol levels FAQ
